npmw-peptide vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2016 (NCT02750995)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- npmw-peptide vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02750995 | Phase 1 | Apr 1, 2016 | Herlev Hospital, Technical University of Denmark, University of Copenhagen |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Herlev Hospital | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Technical University of Denmark | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1